May 2 | News
Drugs approved by the FDA but later re-called, such as Avandia and Vioxx, were the impetus for an Institute of Medicine committee report recommending proactive steps to continue monitoring drugs' safety after initial approval and throughout their time on the market.
|
Apr 4 | News
The FDA is alerting healthcare professionals that another cancer drug, originating from a foreign source and purchased by U.S. medical practices, has been determined to be counterfeit.
|
Feb 24 | News
An FDA panel on Thursday voted 12-2 that there is "substantial evidence to support approval of" Forest Laboratories and Almirall’s aclidinium to reduce complications stemming from chronic obstructive pulmonary disease (COPD).
|
Feb 24 | News
An FDA panel on Thursday voted 7-4 to recommend approval of Chelsea Therapeutics’ Northera (droxidopa) for the treatment of symptomatic neurogenic orthostatic hypotension (NOH) in patients with primary autonomic failure, dopamine beta hydroxylase deficiency or non-diabetic autonomic neuropathy.
|
Feb 20 | News
Deaths from liver-destroying hepatitis C are on the rise, and new data shows baby boomers especially should take heed — they are most at risk.
|
Nov 17 2011 | News
A South African pharmaceutical manufacturer is fighting moves toward banning a painkiller that has been removed from the shelves in the U.S. and Europe because of fears it could harm the heart.
|
Sep 27 2011 | News
Study results published in the American Journal of Gastroenterology suggest that people who are prescribed a large number of antibiotics tend to have a higher risk of inflammatory bowel disease (IBD), Yahoo!Health reported.
|
Sep 27 2011 | News
The FDA said Monday that it "remains concerned" that drospirenone-containing oral contraceptives could raise the risk of venous thromboembolism (VTE) beyond that of other oral contraceptives following a preliminary review of several studies.
|
Sep 9 2011 | News
TRENTON, N.J. (AP) — Outside advisers to the Food and Drug Administration voted Thursday to recommend that the agency approve a new anticlotting drug for use in millions more patients.
|
Aug 25 2011 | News
WASHINGTON (AP) — Federal health regulators are warning doctors not to prescribe high doses of the antidepressant Celexa, because of the risk of fatal heart complications.
|